TriMas (TRS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Completed the Aerospace segment divestiture in March 2026, generating $1.2–$1.24 billion in net after-tax proceeds and strengthening the balance sheet; proceeds earmarked for growth, acquisitions, and share repurchases.
Repurchased 4.5 million shares since the divestiture announcement, reducing shares outstanding to 36.3 million as of March 31, 2026.
Achieved strong Q1 execution with 10.4% net sales growth, driven by organic gains in Packaging and Specialty Products and favorable currency exchange.
Advanced operational improvements, including cost-saving initiatives, facility consolidation, and realignment, expected to yield $10 million in 2026 savings and $15 million annualized.
Maintained focus on organic growth, core capability strengthening, and targeted acquisitions in packaging and life sciences.
Financial highlights
Q1 2026 net sales from continuing operations rose 10.4% year-over-year to $168.3 million, with 7.3% organic growth and a 4% currency tailwind.
Adjusted operating profit increased 32.2% to $12.7 million; adjusted EPS up 60% to $0.24, supported by operating performance and interest income.
Net cash position of $913 million post-divestiture, with cash invested in interest-bearing accounts; ended Q1 with $1.31 billion in cash and equivalents.
Free cash flow was negative $16 million in Q1, reflecting higher investment levels and expected to improve through the year.
Weighted average shares outstanding reduced to 36.3–37.4 million.
Outlook and guidance
Reaffirmed full-year 2026 sales growth guidance of 3%–6% and over 300 basis points of operating margin improvement from 2025's 5.3%.
Full-year 2026 adjusted diluted EPS guidance set at $1.50–$1.70, a 191% increase at midpoint over 2025, assuming $9 million quarterly interest income and $20–$22 million interest expense.
Sequential improvement in sales, earnings, and EPS expected each quarter of 2026.
Over $10 million in cost savings expected in 2026 from realignment and cost actions.
Guidance assumes no material impact from global conflicts or geopolitical actions.
Latest events from TriMas
- Board recommends all proposals as company advances strategy, leadership, and ESG priorities.TRS
Proxy filing31 Mar 2026 - Election of directors, auditor ratification, and say-on-pay up for virtual vote May 20, 2026.TRS
Proxy filing31 Mar 2026 - Strong 2025 results, Aerospace divestiture, and cost actions set up margin growth for 2026.TRS
Q4 202526 Feb 2026 - Packaging and Aerospace drove Q2 growth, but Specialty Products weakness lowered outlook.TRS
Q2 20242 Feb 2026 - Packaging and Aerospace growth offset by Specialty Products decline; 2024 EPS guidance reaffirmed.TRS
Q3 202417 Jan 2026 - Record Aerospace and Packaging growth in Q4 set up 4–6% sales and EPS gains for 2025.TRS
Q4 202423 Dec 2025 - Board refreshment, ESG progress, and performance-based executive pay drive 2025 priorities.TRS
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.TRS
Proxy Filing1 Dec 2025 - Adjusted EPS up 24.3% on 6.4% sales growth; full-year guidance reaffirmed.TRS
Q1 202529 Nov 2025